Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy (Q71024544)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

meta-analysis

0 references

title

Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

acute myocardial infarction

1 reference

1 reference

8

R M Califf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Christopher B. Granger

2

object named as

C B Granger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

author name string

K W Mahaffey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

R Collins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

C M O'Connor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

E M Ohman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

S D Bleich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

J J Col

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

551-556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommitte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: the Duke University Clinical Cardiology Study (DUCCS) 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

The role of anticoagulant therapy in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

Heparin-induced prolongation of partial thromboplastin time after thrombolysis: Relation to coronary artery patency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989305-8

10.1016/S0002-9149(97)89305-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610601%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference